Watch Ticker

Spero Therapeutics, Inc. Common Stock

Go to Spero Therapeutics, Inc. Common Stock Website

$2.11

-0.01 (-0.47%)

Live

Previous Close

$2.12

Day Range

$0 - $0

Previous Day Range

$2.11 - $2.33

Market Cap

$126.4 million USD

Day Vol.

Previous Day Vol.

2.3 million

Currency

USD

Primary Exchange

Nasdaq

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Spero Therapeutics - Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Spero Therapeutics announced interim leadership changes, including the appointment of Esther Rajavelu as Interim President and CEO, and Frank Thomas as Chairman of the Board. The company also provided updates on the Phase 3 PIVOT-PO trial of Tebipenem HBr and its financial position.

Related tickers: SPRO.

Read Full Article

N/A - Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Spero Therapeutics, a biopharmaceutical company, announced the grant of 227,500 restricted stock unit awards to new employees under its 2019 Inducement Equity Incentive Plan. The RSUs will vest over four years, subject to continued employment.

Related tickers: SPRO.

Read Full Article

Trending Tickers

Please sign in to view